Skip to main content

Featured

Daily Markets Update: TSX Rebounds, Europe Hits a Record, Nvidia Shock Rattles Asia (Nov. 12)

  CANADIAN MONEY BRIEF · DAILY MARKETS UPDATE Thursday, November 12, 2026 · Covers Wednesday’s close and Thursday’s Asian session Markets got their AI swagger back on Wednesday — and then Nvidia took some of it away overnight. A strong CoreWeave report lifted tech, pushed the S&P/TSX Composite higher and sent Europe to a record close, but reports that Nvidia’s board is weighing whether to remove CEO Jensen Huang rattled Asian chip stocks on Thursday and pointed U.S. futures lower. AT A GLANCE TSX: +0.67% to 36,411.72, recovering part of Tuesday’s hot-inflation drop. Wall Street: S&P 500 +1.31%, Nasdaq +1.60%, Dow +0.49% as CoreWeave revived the AI trade. Europe: STOXX 600 and Germany’s DAX both closed at records. Asia (Thursday): Taiex -2.63%, Nikkei -0.70% on Nvidia leadership worries. Gold slipped under US$4,000 on a firmer U.S. dollar; oil rebounded from two-month lows. Canada: TSX Claws Back Tuesday’s Loss The S&P/TSX Composite rose 241.27 points, or 0.67%, to...

article

Cancer-Causing Chemical Detected in Acne Treatments: Brands Under Scrutiny

 


In a recent alarming discovery, independent U.S. laboratory Valisure has detected high levels of the cancer-causing chemical benzene in certain acne treatments. Brands affected include:

  1. Clinique (Estee Lauder)
  2. Clearasil (Reckitt Benckiser-owned)
  3. Proactiv
  4. Target Corp.'s Up & Up
  5. PanOxyl
  6. Walgreens’ acne soap bar
  7. Walmart’s Equate Beauty acne cream

Benzene, a known carcinogen, was found not only in the acne products themselves but also in the air around incubated products, suggesting a potential inhalation risk. Valisure has filed a petition with the U.S. Food and Drug Administration (FDA) urging product recalls, investigations, and revised industry guidance. The situation is substantially different from previous cases where benzene impurities came from contaminated ingredients. Here, benzene originates directly from the benzoyl peroxide itself, forming at unacceptably high levels.

Consumers are advised to stay informed as regulatory responses unfold. The FDA’s reaction to Valisure’s petition remains pending. Companies implicated in this issue, including Estee Lauder, have yet to respond to media inquiries.

As we await further developments, it’s crucial to prioritize safety and informed choices when it comes to skincare products. 









Comments